Elevated methylation of cyclin dependent kinase inhibitor 2B contributes to the risk of coronary heart disease in women

Cyclin dependent kinase inhibitor 2B (CDKN2B) encodes a cyclin-dependent kinase inhibitor that may enhance the formation of atherosclerotic plaques. The aim of the present study was to investigate the contribution of CDKN2B promoter methylation on the risk of coronary heart disease (CHD). The presen...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xiaomin, Jiang, Danjie, Xu, Limin, Han, Liyuan, Hu, Haochang, Huang, Yi, Lu, Deyi, Ji, Huihui, Li, Bin, Yang, Yong, Zhou, Cong, Xu, Xuting, Wu, Nan, Xu, Xiaofeng, Xu, Yan, Shen, Yusheng, Li, Jiyi, Duan, Shiwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307461/
https://www.ncbi.nlm.nih.gov/pubmed/30651784
http://dx.doi.org/10.3892/etm.2018.6920

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307461/
https://www.ncbi.nlm.nih.gov/pubmed/30651784
http://dx.doi.org/10.3892/etm.2018.6920

Ejemplares similares